PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
J Cancer
.
2023 May 15;14(8):1335.
doi: 10.7150/jca.85747.
eCollection 2023.
Authors
Ming Li
1
,
Weiwei Zhang
2
,
Shenjun Zhang
3
,
Changhui Wang
1
,
Yinping Lin
1
3
Affiliations
1
Department of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University, Shanghai 200072, China.
2
Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
3
Institute of Biochemistry and Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
PMID:
37283802
PMCID:
PMC10240659
DOI:
10.7150/jca.85747
Abstract
[This retracts the article DOI: 10.7150/jca.18848.].
© Ivyspring International Publisher.
Publication types
Retraction Notice